EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Diagnostic and Prognostic Value of the Left Atrial Myopathy Evaluation in Cardiac Amyloidosis Using Echocardiography

Aaisha Ferkh, Paul Geenty, Luke Stefani, Peter Emerson, Jennifer Pham, Karen Byth, Anita C Boyd, David Richards, Mark S Taylor, Fiona Kwok, Eddy Kizana, Liza Thomas

ESC Heart Failure · 2024

DOI: 10.1002/ehf2.15013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ESC Heart Failure, 2024. Verfasst von Aaisha Ferkh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Westmead Clinical School, University of Sydney, Westmead, New South Wales, Australia. Hauptthemen laut MEDLINE: Heart Atria, Echocardiography, Cardiomyopathies. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of Sydney Faculty of Medicine and Health Executive Dean Stipend Scholarship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cardiac amyloidosis (CA) is an under-recognized cause of heart failure. Left atrial (LA) myopathy contributes to a worse prognosis in heart failure and is a feature of transthyretin (ATTR) and light-chain (AL) CA. LA mechanical dispersion (LA-MD) is a novel marker of intra-atrial dyssynchrony implicated in LA myopathy and the future development of atrial fibrillation (AF).

Aims

This study aimed to determine the characteristics and prognostic value of LA myopathy in ATTR and AL cardiomyopathy through a comprehensive LA echocardiographic evaluation.

Methods

ATTR (n = 86) and AL (n = 86) CA patients were compared with hypertensive heart disease (HHT) patients (n = 58). Transthoracic echocardiographic measurements including LA strain and LA-MD were obtained with patient follow-up for mortality.

Results

ATTR and AL patients had a median follow-up of 66 months, with 26 mortality events. Left ventricular (LV) mass, diastolic function (average-e′ and E/e′), LV global longitudinal strain, and LA volume and function (LA function index and strain) were more impaired in ATTR versus AL; these echocardiographic parameters were more impaired in both amyloid groups compared to HHT patients (P < 0.05). LA-MD was increased in ATTR versus AL [median 72.2 (inter-quartile range 55–88.9) vs. 54 (43.5–64.2), respectively, P < 0.001]. Multivariable logistic regression adjusted for age, presence of AF, LV mass, global and basal strain, and E/e′ demonstrated that LA-MD was an independent determinant of ATTR CA (P = 0.014). On multivariable analysis, LA reservoir strain was independently associated with the presence of heart failure in the CA group (P < 0.001). LA minimum volume (cut-off ≥18 mL/m2) was a determinant of mortality in AL CA [Cox proportional hazard ratio (HR) 1.042 (1.003–1.082), P = 0.034 and Kaplan–Meier analysis, P = 0.016].

Conclusion

Characterizing LA myopathy has significant diagnostic and prognostic utility in CA. ATTR patients have increased atrial dyssynchrony, which may have implications for AF development. LA reservoir strain was associated with heart failure in CA, whilst LA minimum volume was a predictor of mortality in AL CA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart AtriaEchocardiographyCardiomyopathiesHumansMaleFemalePrognosisAgedFollow-Up StudiesAtrial Function, LeftAmyloidosisRetrospective StudiesMiddle Aged

Stichwörter der Autor:innen

cardiac amyloidosisechocardiographyleft atrial mechanical dispersionleft atrial myopathystrain imaging

Autor:innen und Institutionen

  • Westmead Clinical School, University of Sydney, Westmead, New South Wales, Australia.
  • Department of Cardiology, Westmead Hospital, Westmead, New South Wales, Australia.
  • WSLHD Research and Education Network, Westmead Hospital, Westmead, New South Wales, Australia.
  • Westmead Private Cardiology, Westmead, New South Wales, Australia.
  • Department of Clinical Immunology and Allergy, Westmead Hospital, Westmead, New South Wales, Australia.
  • Department of Haematology, Westmead Hospital, Westmead, New South Wales, Australia.

Förderung

  • University of Sydney Faculty of Medicine and Health Executive Dean Stipend Scholarship

Zitieren

APA

Ferkh, A., Geenty, P., Stefani, L., Emerson, P., Pham, J., Byth, K., Boyd, A. C., Richards, D., Taylor, M. S., Kwok, F., Kizana, E., & Thomas, L. (2024). Diagnostic and Prognostic Value of the Left Atrial Myopathy Evaluation in Cardiac Amyloidosis Using Echocardiography. ESC Heart Failure. https://doi.org/10.1002/ehf2.15013

Vancouver

Ferkh A, Geenty P, Stefani L, Emerson P, Pham J, Byth K, et al. Diagnostic and Prognostic Value of the Left Atrial Myopathy Evaluation in Cardiac Amyloidosis Using Echocardiography. ESC Heart Failure. 2024. doi:10.1002/ehf2.15013

BibTeX
@article{Ferkh2024,
  author = {Ferkh, Aaisha and Geenty, Paul and Stefani, Luke and Emerson, Peter and Pham, Jennifer and Byth, Karen and Boyd, Anita C and Richards, David and Taylor, Mark S and Kwok, Fiona and Kizana, Eddy and Thomas, Liza},
  title = {Diagnostic and Prognostic Value of the Left Atrial Myopathy Evaluation in Cardiac Amyloidosis Using Echocardiography},
  journal = {ESC Heart Failure},
  year = {2024},
  doi = {10.1002/ehf2.15013}
}
Kostenlos starten →